Advertisement

Topics

PredictImmune Company Profile

15:49 EDT 24th May 2018 | BioPortfolio


News Articles [3 Associated News Articles listed on BioPortfolio]

PredictImmune secures £4.3m in funding for Crohn's disease biomarker test

PredictImmune has secured £4.3m investment from Wellcome Trust to assess the clinical utility of its prognostic test In Crohn’s disease.

Biomarker Test for Crohn’s Disease Gets Massive Support From Wellcome Trust

PredictImmune has been awarded £4.3M (€4.8M) by the Wellcome Trust to run a clinical trial with its prognostic biomarker test for Crohn’s disease. UK biotech PredictImmune, a developer of pr...

PredictImmune Secures £4.3m Investment from Wellcome Trust to Evaluate The Clinical Utility of Its Prognostic Test In Crohn’s Disease

PredictImmune, a developer of prognostic tools to guide treatment of patients with immune-mediated diseases, announced today that it has been awarded £4.3m by the Wellcome Trust....

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

More Information about "PredictImmune" on BioPortfolio

We have published hundreds of PredictImmune news stories on BioPortfolio along with dozens of PredictImmune Clinical Trials and PubMed Articles about PredictImmune for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PredictImmune Companies in our database. You can also find out about relevant PredictImmune Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record